Sunitinib and Pacritinib: Interaction Details

Brand names
Sunitinib
Sutent
Pacritinib
Vonjo
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

What Happens When You Take Sunitinib With Pacritinib

What can happen when they are taken together (rated Major)

Altered (reduced/increased) SUNItinib exposure, an increased risk of SUNItinib-related adverse reactions, reduced of SUNItinib and an increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Pacritinib should not be given together with a drug known to prolong the , for example SUNItinib. When drugs that prolong the are used together, their effects on QTc may be with those of pacritinib, which raises the risk of cardiac .

Pacritinib should also be avoided in patients whose baseline QTc exceeds 480 msec. Pacritinib should be held if the QT interval prolongs beyond 500 msec or rises by more than 60 msec over baseline.

Should the QTc return to 480 msec or lower, or to baseline, within 1 week, pacritinib can be restarted at the same dose. If resolution takes longer than 1 week, pacritinib should be restarted at a reduced dose.

needs to be corrected before and throughout pacritinib treatment, and QTc prolongation should be managed through interruption of pacritinib along with electrolyte management. Pacritinib acts as a and a , while SUNItinib is a BCRP and a CYP3A4 substrate with a , so the combination may also raise SUNItinib exposure and thereby the risk of SUNItinib adverse reactions.

During , SUNItinib related adverse reactions should be monitored for more frequently, and a SUNItinib dose reduction should be considered. The combination may instead lower SUNItinib exposure, which could reduce its efficacy.

If the two are given together, SUNItinib efficacy should be monitored more often. SUNItinib dose adjustment may be required.1

The Sunitinib and Pacritinib Interaction, Explained

Both of these medicines can affect your heart rhythm. Sunitinib and pacritinib each can lengthen the , a measure of the heart's electrical recharge time. Taking them together may add up and raise the chance of a dangerous irregular heartbeat. Pacritinib may also change how much sunitinib is in your body. That could mean more sunitinib side effects, or less cancer-fighting effect. This is based on drug-behavior reasoning rather than large studies in people.

Please keep taking both exactly as prescribed and talk with your pharmacist or doctor. Your care team can manage this with heart rhythm checks, blood salt (potassium) checks, closer monitoring, and by tailoring your doses if needed.

plus bidirectional effects on sunitinib exposure (evidence: theoretical; severity: major; onset unspecified).

  • Mechanism: both agents prolong . Pacritinib inhibits efflux (may increase sunitinib exposure) and induces (may decrease sunitinib and active exposure). Net direction is uncertain; sunitinib has a .
  • QT management: avoid . Avoid pacritinib if baseline QTc is above 480 msec. Hold pacritinib if QTc exceeds 500 msec or rises more than 60 msec from baseline. If it resolves to 480 msec or less (or baseline) within 1 week, restart at the same dose; if longer, restart at a reduced dose. Correct before and during treatment.
  • Sunitinib: monitor adverse reactions and more frequently; consider dose reduction or adjustment as needed.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Sunitinib and Pacritinib Interact

The likely mechanism

of -mediated efflux transport by pacritinib; of -mediated of SUNItinib;

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Sunitinib and Pacritinib Interaction

Your care team may avoid this combination when possible. If both are needed, they will usually tailor the plan to you.

  • Heart rhythm () may be checked before and during treatment, and potassium levels corrected if low.
  • Pacritinib may be paused if your QTc gets too long, then restarted at the same or a lower dose.
  • Your team may monitor you more closely for sunitinib side effects and for how well it is working, and sunitinib's dose may need to be adjusted and individualized.

Keep taking both as prescribed. Tell your pharmacist or doctor right away about fainting, dizziness, or a racing or irregular heartbeat.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Sunitinib or Pacritinib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

2 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: VONJO oral capsules, pacritinib oral capsules

    In a drug interaction study, giving pacritinib 200 mg twice daily together with rosuvastatin 5 mg (a ) increased the of rosuvastatin by 1.80-fold and its by 2-fold.1

  2. Report 2 · Study title

    Prescribing information: VONJO oral capsules, pacritinib oral capsules

    In a drug interaction study, giving pacritinib 200 mg twice daily together with midazolam (a ) may reduce both the and the of midazolam by 0.40-fold.1

Sunitinib and Pacritinib: Common Questions

How serious is the Sunitinib and Pacritinib interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Sunitinib and Pacritinib interaction managed?

Your care team may avoid this combination when possible. If both are needed, they will usually tailor the plan to you. Heart rhythm () may be checked before and during treatment, and potassium levels corrected if low. Pacritinib may be paused if your QTc gets too long, then restarted at the same or a lower dose. Your team may monitor you more closely for sunitinib side effects and for how well… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Sunitinib and Pacritinib Interaction

Ask in your own words about taking Sunitinib and Pacritinib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: VONJO(R) oral capsules, pacritinib oral capsules. CTI BioPharma Corp (per FDA), Seattle, WA, 2024. DailyMed
Was this write-up helpful?

Other Serious Interactions of Sunitinib and Pacritinib

Also serious with Sunitinib

Also serious with Pacritinib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Sunitinib

With Pacritinib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.